The global Pancreatic Enzymes market was valued at US$ 126.7 million in 2020 and is expected to reach US$ 283.3 million by the end of 2027, growing at a CAGR of 12.2% during 2021-2027.
Pancreatic Enzymes is a mixture of several digestive enzymes produced by the exocrine cells of the pancreas. Pancreatin is usually obtained from the pancreas of pigs or cows. The pancreas is an organ in animals and people that makes chemicals – amylase, lipase, and protease – that are needed for proper digestion. This mixture is used to treat conditions in which pancreatic secretions are deficient, such as surgical pancreatectomy, pancreatitis and cystic fibrosis.
The largest proportion of Pancreatin is used in Pharma Industry, and the consumption proportion is approximately 64% in 2019.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 35 % in 2019. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of over 23%.
Market competition is intense. Shenzhen Hepalink, Nordmark, Sichuan Deebio, ALI, etc. are the leaders of the industry, dominating nearly 30% of the global market. The competitors in tier 2 are Chongqing Aoli, Sichuan Biosyn, Geyuan Tianrun and American Laboratories, Inc. (ALI).
Global Pancreatic Enzymes Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Pancreatic Enzymes Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.
Key Companies profiled in this report are Shenzhen Hepalink, Nordmark, Sichuan Deebio, Sichuan Biosyn, Chongqing Aoli, American Laboratories, Inc. (ALI), Geyuan Tianrun, Spectrum Chemicals and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.
Find more details at: https://www.themarketreports.com/report/global-pancreatic-enzymes-market-outlook
Segment by Type
- Pancreatin Powder
- Pancreatin Pellets
Segment by Application
- Food Processing
- Pharma Industry
Table of Content:
1 Pancreatic Enzymes Market Overview
2 Pancreatic Enzymes Market Competition by Manufacturers
3 Pancreatic Enzymes Retrospective Market Scenario by Region
4 Global Pancreatic Enzymes Historic Market Analysis by Type
5 Global Pancreatic Enzymes Historic Market Analysis by Application
6 Key Companies Profiled
7 Pancreatic Enzymes Manufacturing Cost Analysis
8 Marketing Channel, Distributors and Customers
9 Pancreatic Enzymes Market Dynamics
10 Global Pancreatic Enzymes Market Forecast
11 Research Finding and Conclusion
12 Methodology and Data Source
Company Name: The Market Reports
Contact Person: Shirish Gupta